Algesic actions of the polypeptides and other agents.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001920:Bradykinin; D002217:Carbachol / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007274:Injections, Intraperitoneal; D008688:Methacholine Compounds / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010146:Pain / Q000139:chemically induced*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology*; D011930:Reaction Time; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013157:Splenic Artery; D014667:Vasopressins / Q000494:pharmacology
D002395:Catecholamines; D008688:Methacholine Compounds; D010277:Parasympathomimetics; D010455:Peptides; D014667:Vasopressins; D000804:Angiotensin II; D001115:Arecoline; D010121:Oxytocin; D002217:Carbachol; D001920:Bradykinin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine